Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19

BACKGROUND: Dipeptidyl peptidase-4 inhibitor (DPP-4i) and renin-angiotensin system (RAS) blockade are reported to affect the clinical course of coronavirus disease 2019 (COVID-19) in patients with diabetes mellitus (DM). METHODS: As of May 2020, analysis was conducted on all subjects who could confi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rhee, Sang Youl, Lee, Jeongwoo, Nam, Hyewon, Kyoung, Dae-Sung, Shin, Dong Wook, Kim, Dae Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024148/
https://www.ncbi.nlm.nih.gov/pubmed/33752274
http://dx.doi.org/10.4093/dmj.2020.0206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024148/
https://www.ncbi.nlm.nih.gov/pubmed/33752274
http://dx.doi.org/10.4093/dmj.2020.0206

Ejemplares similares